| abstract |
The present invention relates to a novel β agonist of the following general formula (I): [Chemical 1] (Wherein the radicals R 1 to R 7 are as defined in the claims and specification), and tautomers, enantiomers, diastereomers, mixtures, prodrugs and salts thereof, in particular with inorganic or organic acids or bases Relates to its physiologically acceptable salts. The present invention also relates to a method for producing said compound and its use as a drug. [Selection figure] None |